Schedule 13D ownership disclosure
ENTASIS THERAPEUTICS HLDGS I
Security class unavailable · CUSIP: 293614103
Event date: 2018-09-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-060726
- Form type
- SC 13D
- Filer
- ASTRAZENECA PLC
- CIK
- CIK 901832
- Filed
- Oct 05, 2018
- Reporting period
- Sep 25, 2018
- Description
- Schedule 13D beneficial ownership